Week In Review: WuXi PharmaTech To List Subsidiary On China's Third Board
December 09, 2014 at 17:45 PM EST
China's largest CRO/CMO, has filed to list its chemical manufacturing subsidiary, SynTheAll Pharmaceutical Co. Ltd., on China's Third Board, a two-year old electronic OTC exchange. Shanghai Fosun Pharma will acquire a 65% sake in Suzhou Erye Pharma and more.